Objective The aim of this systematic review was to analyze the evidence about the efficacy of
the several synovial fluid (SF) biomarkers proposed for knee osteoarthritis (OA), categorizing …

In the present study, the levels of synovial fluid biomarkers of patients with knee
osteoarthritis (OA) and those with meniscus injury (MI) were compared to associate the …

Background To identify a synovial fluid (SF) biomarker profile characteristic of individuals
with an inflammatory osteoarthritis (OA) endotype. Methods A total of 48 knees (of 25 …

There is an urgent need for identifying novel serum biomarkers that can be used to improve
diagnosis, predict disease progression or response to therapy, or serve as therapeutic …

Background: There are currently no effective disease-modifying drugs to prevent cartilage
loss in osteoarthritis and synovial fluid is a potentially valuable source of biomarkers to …

Osteoarthritis (OA), affecting 250 million individuals worldwide, is a significant social health
problem. Therefore, the search for synovial fluid (SF) biomarkers that could anticipate the …

Objective The pathophysiology of the most common joint disease, osteoarthritis (OA),
remains poorly understood. Since synovial fluid (SF) bathes joint cartilage and synovium, we …

Osteoarthritis (OA) is a costly and debilitating condition that is typically not diagnosed early
enough to prevent progression of disease. The purpose of this study was to evaluate …

Synovial fluid (SF) is a viscous and mucinous substance produced by the synovium, a
specialized connective tissue that lines diarthrodial joints. SF represents a source of disease …

Osteoarthritis (OA) is a joint degenerative disease that most affects old age. The study of
proteomics in synovial fluid (SF) has the task of providing additional elements to diagnose …